Table 3.
Control Group (n = 25) | RxDx Group (n = 28) | p | |
---|---|---|---|
Initial heparin (mg) | 300 (200–350) | 250 (100–375) | .04 |
Additional heparin (mg) | 100 (0–350) | 62 (0–185) | .04 |
Initial protamine (mg) | 350 (200–500) | 200 (75–340) | .0001 |
Additional protamine (mg) | 50 (0–100) | 40 (0–60) | .1 |
Final ACT (seconds) | 121 (97–138) | 127 (102–138) | .9 |
ACT, activated clotting time.